• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PERFUSION SYSTEMS BIO-MEDICUS NG PEDIATRIC ARTERIAL CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PERFUSION SYSTEMS BIO-MEDICUS NG PEDIATRIC ARTERIAL CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number 96820-112
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Embolism/Embolus (4438)
Event Date 04/22/2020
Event Type  Injury  
Manufacturer Narrative
Article details: title: cerebral protection using percutaneous normothermic bilateral antegrade cerebral perfusion during total arch tevar in a patient with shaggy aorta authors: george joseph, rahul pillai, vinayak shukla, krothapalli s.Babu, shankar manickam, viji samuel thomson, korah t.Kuruvilla, roy thankachen, elizabeth joseph, and raj sahajanandan journal name: journal of endovascular therapy, vol.27(3) 405¿ 413, 2020 doi: 10.1177/1526602820915940.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding cerebral embolic protection (cep) designed for use during thoracic endovascular aortic repair (tevar).The technique is demonstrated in a (b)(6)-year-old male smoker with hypertension and dyslipidemia who was incidentally found to have mediastinal widening on chest radiography.The cep system provided bilateral normothermic acp through percutaneously inserted 12-f and 10-f bio-medicus pediatric arterial cannulas in the right axillary artery (raa) and lcca, respectively.The procedure was performed under general anesthesia after obtaining written informed consent from the patient for the planned procedure and for use of a physician-modified endograft.The mean arterial pressure was maintained above 90 mm hg throughout the procedure.No spinal drain was used.The patient was kept heparinized throughout the procedure, with the activated clotting time maintained at 350 to 400 seconds.The procedure was entirely percutaneous.Duplex ultrasound guidance was used to obtain bilateral femoral arterial and venous, bilateral brachial, and antegrade and retrograde lcca accesses.Dual retrograde raa accesses were obtained using a pigtail catheter inserted from the right brachial artery as a marker.The antegrade lcca access and 1 of the 2 raa accesses were used to insert the short (10-cm) 10-f and 12-f bio-medicus cannulas, respectively, over 0.035-inch guidewires using appropriate dilators.  during the procedure there was slow oozing of blood around the lcca cannula leading to formation of a left neck hematoma.The oozing stopped immediately after removal of the cannula.As a precautionary measure, the patient was extubated the next morning after confirming that there was no increase in size of the neck hematoma.The in-hospital course was otherwise uneventful.There were no neurological deficits or other complications.Postoperative magnetic resonance imaging of the brain showed few small embolic infarcts confined to the right frontal and left cerebellar regions.It was noted that the small embolization that did occur in the present case was probably because the raa cannula flow rate was not sufficiently high; however, this did not result in any early or late neurological deficit.The authors feel that this is acceptable given the extremely diseased nature of the aorta in this patient, a situation where massive cerebral embolization is possible during arch tevar without cep.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIO-MEDICUS NG PEDIATRIC ARTERIAL CANNULA
Type of Device
CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
PERFUSION SYSTEMS
7611 northland dr
brooklyn park MN 55428
Manufacturer (Section G)
PERFUSION SYSTEMS
7611 northland dr
brooklyn park MN 55428
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key11775537
MDR Text Key248986278
Report Number2184009-2021-00029
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K143083
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 05/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number96820-112
Device Catalogue Number96820-112
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/05/2021
Initial Date FDA Received05/05/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age76 YR
-
-